HIV/AIDS Programme Remains Strong Amid Funding Cuts
Discover how South Africa's HIV/AIDS programme is adapting after US funding cuts. The programme remains on solid ground.
SA’s HIV success story creates new challenges
Explore SA's HIV success story: a transformative treatment programme that increases life expectancy and faces new health challenges.
HIV deaths in SA may be four times higher than reported
The latest SAMRC study uncovers severe underreporting of HIV deaths in SA, revealing gaps that demand urgent public health attention.
South Africa intensifies fight against tuberculosis
Challenges in meeting UN Sustainable Development Goals for tuberculosis include late diagnosis, high HIV co-infection, and poverty-related barriers to care.
Sudden USAID withdrawal threatens SA HIV vaccine project
The SA Medical Research Council has appealed for funding after the abrupt termination of US government funding for its leading HIV vaccine project.
HIV programmes: The impact of funding US cuts
US funding cuts to SAs HIV programme threaten to reverse decades of progress, potentially leading to increased infections, hospitalisations, and deaths.
56,000 South Africans succumbed to tuberculosis in 2023
In 2023, tuberculosis was the top infectious disease killer worldwide, with 1.25 million deaths. SA's TB incidence is declining, but fatalities remain high.
Lenacapavir offers key HIV treatment advances
A new HIV prevention drug, lenacapavir, has shown 100% protection in trials, offering hope for young women in Africa. Professor Linda-Gail Bekker believes it could be a game-changer in HIV prevention.
HIV prevalence: health challenges and progress
Women in SA face higher HIV rates due to early sexual activity, low condom use, and multiple partners. Activists urge targeted interventions and support.
Alarming trends in mother-to-child HIV transmission
Sanac aims to test and treat 95% of HIV-infected children, addressing rising infection rates among infants, especially in Tshwane.